Prevalence of statin intolerance: a meta-analysis
Aims Statin intolerance (SI) represents a significant public health problem for which precise
estimates of prevalence are needed. Statin intolerance remains an important clinical …
estimates of prevalence are needed. Statin intolerance remains an important clinical …
A systematic review to assess adherence and persistence with statins
S Deshpande, RGW Quek, CA Forbes… - Current Medical …, 2017 - Taylor & Francis
Objective: To identify and assess studies published over a 10 year period up to February
2016 which measure adherence or persistence with statins, to summarize their methods …
2016 which measure adherence or persistence with statins, to summarize their methods …
Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population
TG Simon, AS Duberg, S Aleman… - Annals of internal …, 2019 - acpjournals.org
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
Y Vinogradova, C Coupland, P Brindle… - bmj, 2016 - bmj.com
Objectives To estimate rates of discontinuation and restarting of statins, and to identify
patient characteristics associated with either discontinuation or restarting. Design …
patient characteristics associated with either discontinuation or restarting. Design …
Postdiagnosis statin use and mortality in Danish patients with prostate cancer
SB Larsen, C Dehlendorff, C Skriver… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Increasing evidence indicates that statin use may reduce mortality from prostate
cancer. In this work, we examined whether postdiagnosis statin use was associated with …
cancer. In this work, we examined whether postdiagnosis statin use was associated with …
Medication nonadherence: health impact, prevalence, correlates and interventions
Nonadherence to medicines is a global problem compromising health and economic
outcomes for individuals and society. This article outlines how adherence is defined and …
outcomes for individuals and society. This article outlines how adherence is defined and …
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
D Tuyet Kristensen, A Kisbye Øvlisen… - Blood …, 2023 - ashpublications.org
Previous studies have indicated a possible cancer-protective effect of statins in solid
cancers; however, this has never been investigated in myeloproliferative neoplasms …
cancers; however, this has never been investigated in myeloproliferative neoplasms …
[HTML][HTML] Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy …
HB Abo-Zalam, ES El-Denshary… - Biomedicine & …, 2021 - Elsevier
This study set out to optimize simvastatin (SV) in lipid nanoparticles (SLNs) to improve
bioavailability, efficacy and alleviate adverse effects. Simvastatin-loaded solid lipid …
bioavailability, efficacy and alleviate adverse effects. Simvastatin-loaded solid lipid …
Characterization of statin low-density lipoprotein cholesterol dose-response using electronic health records in a large population-based cohort
A Oni-Orisan, TJ Hoffmann, D Ranatunga… - Circulation: Genomic …, 2018 - Am Heart Assoc
Background: Low-density lipoprotein cholesterol (LDL-C) response to statin therapy has not
been fully elucidated in real-world populations. The primary objective of this study was to …
been fully elucidated in real-world populations. The primary objective of this study was to …
The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA1c/LDL target achievement in newly diagnosed …
Aims/hypothesis We aimed to assess whether current antidepressant therapy or a history of
hospital-diagnosed depression affects diabetes treatment initiation, adherence, and HbA 1c …
hospital-diagnosed depression affects diabetes treatment initiation, adherence, and HbA 1c …